When antibody levels detected in recovered COVID-19 patients were stratified by time after onset of symptoms (<6 weeks, 6–8 weeks, and >8 weeks), IgM levels gradually declined, while IgG and IgA levels remained significantly higher among patients with pneumonia (S4, S5, and S6 Tables). This evidence concerns the gene CD40LG and pneumonia.